MSD and Sankyo withdraw small cell lung cancer ADC approval application in the US... retrying in phase 3
MSD·산쿄, 소세포폐암 ADC 美 허가신청 철회…3상에 재도전
Reports
- MSD·산쿄, 소세포폐암 ADC 美 허가신청 철회…3상에 재도전MSD and Sankyo withdraw small cell lung cancer ADC approval application in the US... retrying in phase 3cdn.medipana.com · ko ·